Pazopanib as Single Agent in Advanced NETs

NCT01280201 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Advanced/Metastatic Neuroendocrine Tumors

Interventions

DRUG: Pazopanib

Sponsor

Grupo Espanol de Tumores Neuroendocrinos